Influenza virus hemagglutinin proteins and uses thereof Grant US-11865173-B2 United States of America 09 Jan 2024
Influenza virus hemagglutinin proteins and uses thereof Grant US-11266734-B2 United States of America 08 Mar 2022
Anti-influenza B virus neuraminidase antibodies and uses thereof Grant US-11254733-B2 United States of America 22 Feb 2022
MATERIALS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH SULFATASE ENZYMES Application EP-3912635-A1 European Patent Office 24 Nov 2021
Antibodies against influenza virus hemagglutinin and uses thereof Grant US-10544207-B2 United States of America 28 Jan 2020
OLIGOMERIC VACCINES FROM PLANTS BY S-TAG-S-PROTEIN FUSIONS Application WO-2018115305-A1 World Intellectual Property Organisation (WIPO) 28 Jun 2018
Antibodies against influenza virus hemagglutinin and uses thereof Grant US-9908930-B2 United States of America 06 Mar 2018
Vaccines for use in the prophylaxis and treatment of influenza virus disease Grant US-9701723-B2 United States of America 11 Jul 2017
IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of… Grant US-9345760-B2 United States of America 24 May 2016
MATERIALS AND METHODS FOR TREATING DISORDERS ASSOCIATED WITH SULFATASE ENZYMES Application WO-2016007909-A2 World Intellectual Property Organisation (WIPO) 14 Jan 2016
RECOMBINANT TRIVALENT VACCINE AGAINST HUMAN INFLUENZA Application EP-2839840-A4 European Patent Office 15 Apr 2015
RECOMBINANT TRIVALENT VACCINE AGAINST HUMAN INFLUENZA Application EP-2839840-A1 European Patent Office 25 Feb 2015